Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 2
2002 1
2003 3
2004 3
2005 3
2006 4
2007 5
2008 5
2009 13
2010 21
2011 24
2012 24
2013 22
2014 19
2015 25
2016 30
2017 24
2018 22
2019 32
2020 26
2021 27
2022 37
2023 29
2024 25
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

389 results

Results by year

Filters applied: . Clear all
Page 1
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial.
Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Kirste S, Jacobasch L, Allgäuer M, Flentje M, Germer CT, Grützmann R, Hildebrandt G, Schwarzbach M, Bechstein WO, Sülberg H, Friede T, Gaedcke J, Ghadimi M, Hofheinz RD, Rödel C; German Rectal Cancer Study Group. Fokas E, et al. Among authors: polat b. JAMA Oncol. 2022 Jan 1;8(1):e215445. doi: 10.1001/jamaoncol.2021.5445. Epub 2022 Jan 20. JAMA Oncol. 2022. PMID: 34792531 Free PMC article. Clinical Trial.
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.
Fokas E, Allgäuer M, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Schmiegel W, Jacobasch L, Weitz J, Folprecht G, Schlenska-Lange A, Flentje M, Germer CT, Grützmann R, Schwarzbach M, Paolucci V, Bechstein WO, Friede T, Ghadimi M, Hofheinz RD, Rödel C; German Rectal Cancer Study Group. Fokas E, et al. Among authors: polat b. J Clin Oncol. 2019 Dec 1;37(34):3212-3222. doi: 10.1200/JCO.19.00308. Epub 2019 May 31. J Clin Oncol. 2019. PMID: 31150315 Clinical Trial.
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings.
Hummel HD, Kufer P, Grüllich C, Seggewiss-Bernhardt R, Deschler-Baier B, Chatterjee M, Goebeler ME, Miller K, de Santis M, Loidl W, Dittrich C, Buck A, Lapa C, Thurner A, Wittemer-Rump S, Koca G, Boix O, Döcke WD, Finnern R, Kusi H, Ajavon-Hartmann A, Stienen S, Sayehli CM, Polat B, Bargou RC. Hummel HD, et al. Among authors: polat b. Immunotherapy. 2021 Feb;13(2):125-141. doi: 10.2217/imt-2020-0256. Epub 2020 Nov 10. Immunotherapy. 2021. PMID: 33172323 Free article. Clinical Trial.
Survival among patients treated with total mesorectal excision or selective watch-and-wait after total neoadjuvant therapy: a pooled analysis of the CAO/ARO/AIO-12 and OPRA randomized phase II trials.
Williams H, Fokas E, Diefenhardt M, Lee C, Verheij FS, Omer DM, Lin ST, Dunne RF, Marcet J, Cataldo P, Polite B, Piso P, Polat B, Dapper H, Ghadimi M, Hofheinz RD, Qin LX, Saltz LB, Wu AJ, Gollub MJ, Smith JJ, Weiser MR, Rödel C, Garcia-Aguilar J; German Rectal Cancer Study Group; OPRA Consortium. Williams H, et al. Among authors: polat b. Ann Oncol. 2025 May;36(5):543-547. doi: 10.1016/j.annonc.2025.01.006. Epub 2025 Jan 21. Ann Oncol. 2025. PMID: 39848335 Clinical Trial.
Are we closer to achieving precision medicine for migraine treatment? A narrative review.
Ihara K, Casillo F, Dahshan A, Genç H, Jusupova A, Karbozova K, Lee W, Liaw YC, Mavridis T, Park HK, Polat B, Unt TH, Vashchenko N, Zhantleuova A, Pozo-Rosich P, Schwedt TJ. Ihara K, et al. Among authors: polat b. Cephalalgia. 2024 Sep;44(9):3331024241281518. doi: 10.1177/03331024241281518. Cephalalgia. 2024. PMID: 39256924 Free article. Review.
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials.
Dal Pra A, Ghadjar P, Ryu HM, Proudfoot JA, Hayoz S, Michalski JM, Spratt DE, Liu Y, Schär C, Berlin AM, Zwahlen DR, Simko JP, Hölscher T, Efstathiou JA, Polat B, Sandler HM, Hildebrandt G, Parliament MB, Mueller AC, Dayes IS, Plasswilm L, Correa RJM, Robertson JM, Karrison TG, Davicioni E, Hall WA, Feng FY, Pollack A, Thalmann GN, Nguyen PL, Aebersold DM, Tran PT, Zhao SG. Dal Pra A, et al. Among authors: polat b. Ann Oncol. 2025 May;36(5):572-582. doi: 10.1016/j.annonc.2025.01.017. Epub 2025 Feb 13. Ann Oncol. 2025. PMID: 39986927 Free article. Clinical Trial.
Metallic Nanoislands on Graphene for Biomechanical Sensing.
Ramírez J, Polat B, Lipomi DJ. Ramírez J, et al. Among authors: polat b. ACS Omega. 2020 Jun 23;5(26):15763-15770. doi: 10.1021/acsomega.0c01967. eCollection 2020 Jul 7. ACS Omega. 2020. PMID: 32656394 Free PMC article. Review.
Radiotherapy in adrenocortical carcinoma.
Polat B, Fassnacht M, Pfreundner L, Guckenberger M, Bratengeier K, Johanssen S, Kenn W, Hahner S, Allolio B, Flentje M. Polat B, et al. Cancer. 2009 Jul 1;115(13):2816-23. doi: 10.1002/cncr.24331. Cancer. 2009. PMID: 19402169 Free article. Review.
Corrigendum to "Re-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes" [Europ. J. Paediatr. Neurol. 41 (2022) 8-18 doi.org/10.1016/j.ejpn.2022.08.006].
Yılmaz Ü, Gücüyener K, Yavuz M, Ibrahim Oncel, Canpolat M, Saltık S, Ünver O, Çıtak Kurt AN, Tosun A, Yılmaz S, Özgör B, İlknur Erol, Öztoprak Ü, Elitez DA, Çobanoğulları Direk M, Bodur M, Teber S, Anlar B; Turkish Pediatric Multiple Sclerosis Study Group. Yılmaz Ü, et al. Eur J Paediatr Neurol. 2024 Dec 2:S1090-3798(24)00172-7. doi: 10.1016/j.ejpn.2024.11.006. Online ahead of print. Eur J Paediatr Neurol. 2024. PMID: 39627061 No abstract available.
389 results